Taiwan and Singapore back NSV’s US$53M bet on Asia’s biotech pipeline

e27 - Nov 3, 2026

Raising a debut fund in 2026 is hard. Raising one for biotech, a sector investors have spent four years avoiding, is harder still. NeoSci Ventures (NSV) says it has done it anyway. The Singapore-, Taiwan- and US-based venture builder has announced a first close of SGD70 million (US$53 million) for its inaugural institutional fund. The […] The post Taiwan and Singapore back NSV’s US$53M bet on Asia’s biotech pipeline appeared first on e27.

Read full article
MORE NEWS

SainsKini is established to address and cover all notable science and technology discoveries made in the region and properly credit them for the whole world to acknowledge.